Armistice Capital, LLC 13D/13G Filings for Caladrius Biosciences, Inc. (CLBS)

Armistice Capital, LLC 13D and 13G filings for Caladrius Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-02-16
2:57 pm
Purchase		 2020-12-31 13G Caladrius Biosciences, Inc.
CLBS		 Armistice Capital, LLC 53,410
4.000%		 2,508increase
(+4.93%)		 Filing
2020-05-04
5:24 pm
Purchase		 2020-04-23 13G Caladrius Biosciences, Inc.
CLBS		 Armistice Capital, LLC 50,902
6.000%		 50,902increase
(New Position)		 Filing